Largemouth bass virus (LMBV), a member of the Ranavirus genus within the Iridoviridae family, is a significant pathogen causing high mortality and substantial economic losses in largemouth bass aquaculture. Therefore, developing effective antiviral agents against this viral infection is crucial for the largemouth bass aquaculture industry. Quercetin, a widely utilised flavonoid known for its therapeutic and prophylactic properties, was investigated for its antiviral efficacy against LMBV and underlying mechanisms in this study. The results demonstrated that quercetin significantly inhibited LMBV propagation in vitro and in vivo, and was effective in both prevention and treatment stages. Specifically, quercetin at 6.25 μg/mL suppressed LMBV (major capsid protein) MCP gene transcription by up to 92.09%, with the post-infection treatment achieving 99.33% inhibition in vitro. Mechanistic studies revealed that quercetin reduces LMBV infectivity by disrupting viral internalisation and replication, while also potentiating cellular immune responses mediated by the IFN system. In vivo experiments further confirmed that quercetin treatment reduced viral transcription in the liver, spleen and kidney by 97.49%, 47.45% and 98.42%, respectively, at 48 h post-infection and significantly enhanced the survival rate of infected juveniles. In conclusion, quercetin demonstrated potent antiviral activity against LMBV and might serve as a promising, eco-friendly antiviral agent.
Huang et al. (Wed,) studied this question.